WSB2
Basic information
Region (hg38): 12:118032687-118062430
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the WSB2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 15 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 3 | 2 |
Variants in WSB2
This is a list of pathogenic ClinVar variants found in the WSB2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-118034206-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
12-118034329-G-C | not specified | Uncertain significance (Mar 20, 2023) | ||
12-118035287-C-T | not specified | Uncertain significance (Jun 02, 2023) | ||
12-118035293-T-C | not specified | Uncertain significance (Jun 29, 2023) | ||
12-118035305-C-T | not specified | Uncertain significance (Dec 11, 2023) | ||
12-118036386-T-C | not specified | Uncertain significance (Apr 19, 2024) | ||
12-118036424-G-A | Likely benign (Jun 01, 2022) | |||
12-118036433-G-A | Benign (Jul 04, 2018) | |||
12-118038289-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
12-118038300-A-G | Likely benign (Jan 01, 2023) | |||
12-118042862-T-C | not specified | Uncertain significance (Jan 10, 2023) | ||
12-118042916-T-C | Benign (Jul 04, 2018) | |||
12-118043202-C-T | Likely benign (Jan 01, 2023) | |||
12-118043222-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
12-118043229-A-G | not specified | Uncertain significance (Jul 29, 2022) | ||
12-118043243-G-T | not specified | Uncertain significance (Nov 09, 2022) | ||
12-118043273-C-G | not specified | Uncertain significance (Jan 04, 2024) | ||
12-118043298-G-C | not specified | Uncertain significance (Mar 04, 2024) | ||
12-118043322-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
12-118043324-C-T | not specified | Uncertain significance (Aug 17, 2021) | ||
12-118052428-C-G | not specified | Uncertain significance (Mar 24, 2023) | ||
12-118062151-G-A | Benign (Jul 04, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
WSB2 | protein_coding | protein_coding | ENST00000315436 | 9 | 29524 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.929 | 0.0706 | 125739 | 0 | 8 | 125747 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.14 | 144 | 237 | 0.608 | 0.0000137 | 2636 |
Missense in Polyphen | 25 | 82.329 | 0.30366 | 892 | ||
Synonymous | -0.541 | 109 | 102 | 1.07 | 0.00000671 | 801 |
Loss of Function | 3.72 | 3 | 21.7 | 0.138 | 0.00000108 | 232 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000353 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. {ECO:0000250}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.0814
Intolerance Scores
- loftool
- 0.356
- rvis_EVS
- 0.22
- rvis_percentile_EVS
- 68.13
Haploinsufficiency Scores
- pHI
- 0.0739
- hipred
- Y
- hipred_score
- 0.768
- ghis
- 0.443
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.757
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Wsb2
- Phenotype
- homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; skeleton phenotype; vision/eye phenotype; limbs/digits/tail phenotype; reproductive system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein ubiquitination;intracellular signal transduction;post-translational protein modification
- Cellular component
- cytosol
- Molecular function